Welcome To The MAP Newsletter

  The official newsletter of the International Society for Medical Publication Professionals


ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals



ISMPP Highlights

ISMPP Member Publications and Presentations

ISMPP is pleased to share these recent publications and presentations by Society members. We encourage our members to publish and present research and information related to publishing practices to advance the medical publications profession, and improve standards and best practices…

13th Annual Meeting of ISMPP – A Great Success!

The 13th Annual Meeting of ISMPP was a great success, with its programming focused on the meeting theme, Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data Sharing. Over 560 attendees participated in the meeting, held May 1-3, 2017, at the Gaylord National Resort and Convention Center, in National Harbor, Maryland, USA…

Advocacy & Outreach Committee Focuses on Strategic Targets

One aspect of ISMPP’s mission is to advance the medical publication profession globally through education, advocacy, and professional collaborations. ISMPP fulfills this mission in various ways, with the Advocacy & Outreach (A&O) Committee serving a key role. The current A&O Committee is focusing its effort on three strategic targets…

Message from Our Leadership

Carolyn Hustad
At-Large Trustee, 2017-2018 ISMPP Board of Trustees

Read Carolyn's Message

News and Trends

Publication Planning: Balancing Speed vs Story Flow

In the evolving landscape of medical publications, the question of whether to release study data as soon as they are available or to plan release based on a “story flow” is front-and-center. Recent regulation changes on the release of clinical trial results are an important consideration and will likely continue to have an impact on publication planning…

A New Age of Transparency: Do We Fully Understand the Implications?

Over the last few years, requirements for clinical trial transparency and data reporting have become more extensive to help patients and health care practitioners (HCPs) better understand the drugs they are taking or prescribing in clinical trials, with a focus on increasing trust and confidence in regulatory decisions on medicines. Publication professionals within sponsor companies must…